Your search history is turned on.
Date: May 8, 2024 07:18:30 EST Jurisdictions: All jurisdictions
Oncolytics Biotech to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference Oncolytics Biotech to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference SAN DIEGO and CALGARY, AB, May 8, 2024 /CNW/ -- Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncolo...
Date: April 30, 2024 Jurisdictions: All jurisdictions
Oncolytics Biotech to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights Oncolytics Biotech to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights Conference call and webcast to take place on Thursday, May 9, 2024, at 4:30 p.m. ET SAN DIEGO and CALGARY, AB, April 30, 2024 /CNW/ -- Oncolytics Biotech Inc...
Date: April 25, 2024 Jurisdictions: All jurisdictions
Oncolytics Biotech Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting Oncolytics Biotech Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting SAN DIEGO and CALGARY, AB, April 25, 2024 /CNW/ -- Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncolog...
Date: April 12, 2024 Jurisdictions: All jurisdictions
At the discretion of the said proxyholders, upon any amendment or variation of the above matters or any other matter that may be properly brought before the Meeting or any adjournment or postponement thereof in such manner as such proxy, in such proxyholder's sole judgment, may determine. The undersigned hereby revokes any proxies previously give...
NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON MAY 15, 2024 - AND - MANAGEMENT INFORMATION CIRCULAR MARCH 26, 2024 March 26, 2024 Dear Shareholder: Important Notice regarding Participat...
4 NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS NOTICE IS HEREBY GIVEN that an annual meeting (the Meeting) of the holders (Shareholders) of common shares of Oncolytics Biotech Inc. (the Corporation) will be held as follows: When: Wednesday, May 15, 2024 at 4:00 p.m...
Date: April 11, 2024 Jurisdictions: All jurisdictions
Oncolytics Biotech Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA Oncolytics Biotech Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA Requested for Q2 2024, the Type C meeting is to focus on planned registration-enabling trial in HR+/HER2- metasta...
Date: April 2, 2024 Jurisdictions: All jurisdictions
Oncolytics Biotech to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference Oncolytics Biotech to Participate in a Panel Presentation at Canaccord Genuity's Horizons in Oncology Virtual Conference SAN DIEGO and CALGARY, AB, April 2, 2024 /CNW/ -- Oncolytics Biotech Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focused on on...
Date: March 12, 2024 Jurisdictions: All jurisdictions
EX. 13.2 CFO Certification 2023-2024-03-12-12-44 EXHIBIT 12.2 CERTIFICATION I, Kirk Look, certify that: 1. I have reviewed this annual report on Form 20-F of Oncolytics Biotech Inc.; 1. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made...
EX. 12.1 CEO Certification 2023-2024-03-12-12-43 EXHIBIT 12.1 CERTIFICATION I, Matthew Coffey, certify that: 1. I have reviewed this annual report on Form 20-F of Oncolytics Biotech Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in...